Allogene Therapeutics, Inc. (ALLO)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
1.1652 wk Range
1.04Overview - ALLO - Allogene Therapeutics, Inc.
Key Statistics
Valuation
Enterprise Value
240.45M
P/E (Trailing)
-1.61
P/E (Forward)
-2.36
PEG Ratio
0.03
Price / Sales (TTM)
108.71
Price / Book
1.15
EV / EBITDA
-1.42
Profitability
Profit Margin
0.00%
Operating Margin
-1,011.20%
Return on Assets
-22.08%
Return on Equity
-42.39%
Ownership
Shares Outstanding
345.34M
Float
281.13M
Short % of Shares Outstanding
19.09%
Held by Insiders
11.03%
Held by Institutions
82.61%
Price stats
Beta
0.55
50-Day Avg
1.84
200-Day Avg
1.99
Analyst Consensus
12 analysts
Average price target
$ 9.00Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ALLO - Allogene Therapeutics, Inc.
Peers - ALLO - Allogene Therapeutics, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ALLONASDAQAllogene Therapeutics, Inc.483.68MMarket Cap+12.14%52-week change-1.61P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - ALLO - Allogene Therapeutics, Inc.
About
Allogene Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic, or donor-derived, CAR T cell therapies for cancer and autoimmune disease. The company’s current work centers on investigational off-the-shelf cell therapy candidates designed to be manufactured from healthy donor…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
